Clinical Trial Update: Study to Assess the Safety, Tolerability, Pharmacokinetic of Thrv-1268 [Phase 1]

View source ↗

Summary

A Phase 1 trial of Thrv-1268 completed, evaluating its safety, tolerability, and pharmacokinetics in patients with atrial fibrillation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Thrv-1268

Snippet

Sponsor: Thryv Therapeutics, Inc. | Conditions: Atrial Fibrillation | Phase 1 | Status: COMPLETED